Palmoplantar pustulosis https://en.wikipedia.org/wiki/Pustulosis_palmaris_et_plantaris
Ko te Palmoplantar pustulosis he pustular dermatosis mau tonu (ara, he pustulosis, he psoriasis pustular) kei runga i nga nikau me nga kapu anake, e tohuhia ana e nga pustules intraepidermal kua whakakiia ki te neutrophils. Ko te whakamahi i nga retinoids punaha anake me te whakakotahi me te photochemotherapy hei whakapai ake i nga tohu o palmoplantar pustulosis.

○ Maimoatanga
He whai hua te acitretin waha mo tenei momo psoriasis.
#Acitretin
Ētahi atu korero ― Maori
References Palmoplantar Psoriasis 28846363 
NIH
Ko te Palmoplantar pustulosis he momo pustulosis ka pa te nuinga o te kiri ki o ringaringa me o kapu. Ka kitea he kiri matotoru me te maroke, te pupuhi, te huinga rānei o ngā momo e rua.
Palmoplantar psoriasis is a variant of psoriasis that characteristically affects the skin of the palms and soles. It features hyperkeratotic, pustular, or mixed morphologies.
 Tumor Necrosis Factor Inhibitors 29494032 
NIH
Tumor necrosis factor (TNF)-alpha inhibitors, including etanercept (E), infliximab (I), adalimumab (A), certolizumab pegol (C), and golimumab (G), are biologic agents which are FDA-approved to treat ankylosing spondylitis (E, I, A, C, and G), Crohn disease (I, A and C), hidradenitis suppurativa (A), juvenile idiopathic arthritis (A), plaque psoriasis (E, I and A), polyarticular juvenile idiopathic arthritis (E), psoriatic arthritis (E, I, A, C, and G), rheumatoid arthritis (E, I, A, C, and G), ulcerative colitis (I, A and G), and uveitis (A).